AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimital-M 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Talent India

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimital-M 1 Tablet PR

DiaBeta-Duo, a single-dose tablet, is an antidiabetic medication combining two active ingredients for adult type 2 diabetes management. It effectively regulates blood glucose. Administer DiaBeta-Duo with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may adjust based on your blood sugar response. Continue taking DiaBeta-Duo even with controlled blood sugar; unsupervised cessation risks elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, DiaBeta-Duo complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect. Learn to identify symptoms like sweating, lightheadedness, headache, and tremors, and know how to treat them. Maintain regular meals and carry a fast-acting glucose source, such as sweets or juice. Alcohol elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. DiaBeta-Duo is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Inform your physician of any prior heart conditions before commencing treatment; it may be unsuitable. Consult your doctor before using DiaBeta-Duo if pregnant or breastfeeding. Regular blood glucose monitoring is essential; additional blood tests for blood cell counts and liver function may be recommended by your physician.

Uses of Glimital-M 1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimital-M 1 Tablet PR:

Follow your physician's instructions or consult the product labeling for usage guidelines. Administer Glimital-M 1 Tablet PR with a meal.

Common Side effects of Glimital-M 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimital-M 1 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidance. Administer one Glimital-M tablet (PR) with a meal.

How Glimital-M 1 Tablet PR works:

Glimepiride and Metformin, combined as Glimital-M 1 Tablet PR, offer a dual approach to diabetes management. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness throughout the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glimital-M 1 Tablet PR ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimital-M 1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Maternal use of Glimital-M 1 Tablet PR is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimital-M 1 Tablet PR cautiously, potentially requiring a modified dosage. Consult your physician for guidance. Glimital-M 1 Tablet PR is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimital-M 1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate liver disease; Glimital-M 1 Tablet PR is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimital-M 1 Tablet PR :

Should you forget a Glimital-M 1 Tablet PR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimital-M 1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimital-M 1 Tablet PR

Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimital-M 1 Tablet PR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimital-M 1 Tablet PR and seek immediate medical attention.
Glimital-M 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for treating type 1 DM.
Glimital-M 1 Tablet PR may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimital-M 1 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimital-M 1 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimital-M 1 Tablet PR with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimital-M 1 Tablet PR
53
MRP 61
12% off